hydralazine has been researched along with Cancer of Pancreas in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, KM | 1 |
| Cornnell, HH | 1 |
| Ibrahim-Hashim, A | 1 |
| Wojtkowiak, JW | 1 |
| Hart, CP | 1 |
| Zhang, X | 1 |
| Leos, R | 1 |
| Martinez, GV | 1 |
| Baker, AF | 1 |
| Gillies, RJ | 1 |
| Jones, GR | 1 |
2 other studies available for hydralazine and Cancer of Pancreas
| Article | Year |
|---|---|
Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Blood Circulation; Cell Hypoxia; Cell Line, Tumor; D | 2014 |
Interference with energy production as a means of causing injury to a human pancreatic carcinoma.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Energy Metabolism; | 1983 |